Study guide

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family

Key Takeaways Explain This Topic AI

The IJCAHPO history content area names exactly five domains: ocular, medical, medication, social and family.

A chief complaint is recorded in the patient's own words, then characterised by onset, duration, laterality, severity, quality and modifying factors.

Medication history must include over-the-counter drops, supplements and herbal products because tamsulosin, amiodarone, hydroxychloroquine and anticholinergics all change ophthalmic management.

Family history of glaucoma, retinal detachment, macular degeneration and retinoblastoma changes screening intervals and must be recorded with the relationship and age of onset.

Open-ended questions gather content; closed questions confirm specifics — use open first, then narrow.

Last updated: September 2026

Why history is a scored content area

History and Documentation is 3% of the COMT examination — roughly six items — but its real weight is larger, because scenario questions in motility, pharmacology, patient services and supplemental testing all open with a history. A candidate who reads histories well answers those items faster.

IJCAHPO names five history domains: ocular, medical, medication, social and family . Cover all five and the record is complete.

The chief complaint

Record the chief complaint in the patient's own words , in quotation marks, then characterise it. A reliable structure:

  • Element Question that gets it
  • Onset "When did you first notice it?"
  • Duration / course "Is it constant or does it come and go? Getting better or worse?"
  • Laterality "One eye or both? Does it change if you cover one eye?"
  • Severity "How much does it interfere with what you need to do?"
  • Quality "Describe it — blurry, double, a curtain, flashes, a shadow?"
  • Associated symptoms Pain, photophobia, discharge, headache, nausea, neurological signs
  • Modifying factors "Anything that makes it better or worse? Distance versus near? Light versus dark?"
  • Prior episodes and treatment "Has this happened before? What was done?"

The laterality question is the one technologists most often get wrong. Patients frequently report a "right eye problem" that is actually a right visual field defect in both eyes. Asking the patient to cover each eye separately resolves it in ten seconds and can be the difference between a routine refraction and a stroke referral.

Red-flag symptoms

These change the appointment, not just the record:

Sudden painless loss of vision — vascular occlusion, retinal detachment, vitreous haemorrhage.

New flashes with a shower of floaters, or a curtain — retinal tear or detachment.

Pain with nausea, vomiting and haloes — acute angle closure.

New binocular diplopia — cranial nerve palsy; ask about pain, headache and pupil size.

Headache with jaw claudication or scalp tenderness in a patient over 50 — giant cell arteritis.

Chemical splash — irrigate first, take the history second.

Transient monocular loss lasting minutes — amaurosis fugax, a carotid warning.

Ocular history

Previous refractive error and spectacle or contact lens wear; previous eye surgery with dates (refractive surgery invalidates standard intraocular lens formulas and changes keratometry interpretation); ocular trauma; amblyopia, patching or strabismus surgery in childhood; previous diagnoses of glaucoma, uveitis, retinal disease or dry eye; current ocular medications with frequency and last dose; date and result of the last eye examination.

Medical history

Record systemic diagnoses with control status and duration, not just names. "Diabetes" is inadequate; "type 2 diabetes for 14 years, most recent HbA1c 9.2%" predicts retinopathy risk. Ask specifically about diabetes, hypertension, thyroid disease, autoimmune disease, cancer, neurological disease, sickle cell trait or disease, and pregnancy (which affects both drug choice and refractive stability). Record blood pressure and pulse when the protocol calls for it.

Medication history — where errors hide

Ask for the actual bottles or a current list. Cover:

Prescription systemic drugs and the reason for each.

Topical ocular drops , including the cap colour, because patients often know the colour and not the name.

Over-the-counter products , including decongestant drops (rebound hyperaemia) and artificial tears.

Supplements and herbal products.

Allergies and the nature of the reaction — a rash is not the same as anaphylaxis, and "allergic to iodine" requires careful clarification before any antisepsis or angiography.

Four systemic drug classes must be actively elicited because they change the ophthalmic plan:

Drug Ophthalmic consequence

Tamsulosin and other alpha-1 blockers Intraoperative floppy iris syndrome; surgeon must know before cataract surgery

  • Hydroxychloroquine Retinal toxicity; requires baseline and interval screening with visual fields and OCT
  • Amiodarone Vortex keratopathy; rarely optic neuropathy

Anticholinergics, some antihistamines, topiramate Angle-closure risk; topiramate causes acute myopic shift with angle closure

Also flag corticosteroids (cataract, raised pressure), ethambutol (optic neuropathy), sildenafil-class drugs (transient blue tinge), isotretinoin (dry eye, lens intolerance) and anticoagulants (bleeding risk for injections and surgery).

Social history

Occupation and visual demands (welder, night driver, microscope user, screen hours), hobbies, driving status and any licensing vision standard, smoking (a strong modifiable risk factor for macular degeneration and thyroid eye disease), alcohol, recreational drug use, and living circumstances that affect compliance with a four-times-daily drop regimen. For contact lens wearers add water exposure, sleeping in lenses and replacement habits.

Family history

Record the relationship and the age at onset , not just the condition.

Glaucoma — first-degree relative history substantially raises risk and lowers the screening threshold.

Retinal detachment and high myopia.

Age-related macular degeneration.

Retinoblastoma — heritable in a significant fraction; changes paediatric screening entirely.

Keratoconus , colour vision deficiency, retinitis pigmentosa and other hereditary dystrophies.

Strabismus and amblyopia.

Systemic hereditary disease with ocular involvement such as Marfan syndrome, neurofibromatosis and sickle cell disease.

Interviewing technique

Start open ("What brings you in today?"), let the patient finish, then narrow with closed questions to pin specifics. Avoid leading questions — "Does it hurt?" invites a yes. Use plain language: patients do not know what "photophobia" or "metamorphopsia" mean; ask about "light hurting your eyes" and "straight lines looking wavy." Use a professional interpreter rather than a family member when there is a language barrier, and document that an interpreter was used. When a patient has hearing loss, face them, speak at normal volume and confirm understanding rather than shouting.